Vascor

The Vascor ventricular assist device treats severe heart failure without the serious adverse complications suffered by patients who receive current VAD pumps.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Pittsburgh, PA, US
  • Currency USD
  • Founded July 1992
  • Employees 4
  • Incorporation Type C-corp
  • Website vascor.com

Company Summary

Severe heart failure is treated with a ventricular assist device (VAD). In 2015, sales of currently FDA approved VADs totaled > $760 million. First year serious adverse event (blood clots, stroke, bleeding, infection and death) rates for these products is 70%. Vascor's patent protected VAD innovations (pushing blood vs. spinning impeller rotary pumps and transcutaneous energy transmission vs. driveline) eliminate these complications.

Team

  • CEO Medrad. Grew revenues from $125 million to $700 million via product development and international market penetration. Two time recipient Presidential Malcolm Baldrige Performance Excellence Award. Global company. 2500 employees. Ancillary imaging equipment.

    Other: Director Daktronics (DAKT); Managing Director, Preservation Technologies; Director, several medical device entrepreneurial companies; several community boards.

  • M. Stephen Heilman MD
    Founder and CTO

    Founded Medrad. Sold to Schering 1995. Ancillary imaging equipment. Current revenues $700 million. Founded Intec Systems. Sold to Eli Lilly 1986. Implantable defibrillator (ICD). Current revenues $6 billion. Founded Lifecor. Sold to Zoll 2006. Wearable defibrillator. Current revenues $600 million.

    Numerous patents. Inducted into National Inventors Hall of Fame for the ICD.

  • David Reilly
    Mechanical Engineer

    Forty years design experience with Medrad. Awarded over 70 US and Foreign patents. Products using Dave's designs benefit hundreds of millions of patients annually.

Advisors

  • Maria Fagan, Regulatory and Quality Solutions LLC
    Unconfirmed
  • Mark Wholey MD; Interventional Cardiology UPMC Shadyside Hospital
    Unconfirmed
    Mark Slaughter MD; University of Louisville Cardiovascular Innovation Institute
    Unconfirmed

Previous Investors

  • Steven Robinson
    Unconfirmed
    Mark Wholey MD
    Unconfirmed
    Marlin S Heilman MD
    Unconfirmed
  • Gerald McGinnis
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free